PRDM15 Human shRNA Plasmid Kit (Locus ID 63977)
CAT#: TL302293
PRDM15 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 7740.00
Product images

CNY 4070.00
Specifications
Product Data | |
Product Name | PRDM15 Human shRNA Plasmid Kit (Locus ID 63977) |
Locus ID | 63977 |
UniProt ID | P57071 |
Synonyms | C21orf83; PFM15; ZNF298 |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | PRDM15 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 63977). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | NM_001040424, NM_001282934, NM_022115, NM_144771, NR_104257, NR_104258, NR_104260, NR_135464, NM_001040424.1, NM_001040424.2, NM_022115.1, NM_022115.2, NM_022115.3, NM_022115.4, NM_001282934.1, BC032305, BC067102, BM544857, BM755202 |
Summary | Sequence-specific DNA-binding transcriptional regulator. Plays a role as a molecular node in a transcriptional network regulating embryonic development and cell fate decision. Stimulates the expression of upstream key transcriptional activators and repressors of the Wnt/beta-catenin and MAPK/ERK pathways, respectively, that are essential for naive pluripotency and self-renewal maintenance of embryonic stem cells (ESCs). Specifically promotes SPRY1 and RSPO1 transcription activation through recognition and direct binding of a specific DNA sequence in their promoter regions. Involved in early embryo development (By similarity). Plays also a role in induced pluripotent stem cells (iPSCs) reprogramming (PubMed:28740264).[UniProtKB/Swiss-Prot Function] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Documents
Product Manuals |
FAQs |
SDS |